Cargando…

Prostaglandin E Receptor Subtype 4 Signaling in the Heart: Role in Ischemia/Reperfusion Injury and Cardiac Hypertrophy

Prostaglandin E(2) (PGE(2)) is an endogenous lipid mediator, produced from the metabolism of arachidonic acids, upon the sequential actions of phospholipase A2, cyclooxygenases, and prostaglandin E synthases. The various biological functions governed by PGE(2) are mediated through its four distinct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pang, Lei, Cai, Yin, Tang, Eva Hoi Ching, Irwin, Michael G., Ma, Haichun, Xia, Zhengyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846751/ https://www.ncbi.nlm.nih.gov/pubmed/27190998 http://dx.doi.org/10.1155/2016/1324347

Ejemplares similares

Cox-2 Inhibition Protects against Hypoxia/Reoxygenation-Induced Cardiomyocyte Apoptosis via Akt-Dependent Enhancement of iNOS Expression
por: Pang, Lei, et al.
Publicado: (2016)

Renal ischemia/reperfusion-induced cardiac hypertrophy in mice: Cardiac morphological and morphometric characterization
por: Cirino-Silva, Rogério, et al.
Publicado: (2017)

MicroRNA-503 Exacerbates Myocardial Ischemia/Reperfusion Injury via Inhibiting PI3K/Akt- and STAT3-Dependent Prosurvival Signaling Pathways
por: He, Yanjing, et al.
Publicado: (2022)

aYAP modRNA reduces cardiac inflammation and hypertrophy in a murine ischemia-reperfusion model
por: Chen, Jinmiao, et al.
Publicado: (2019)

N-Acetylcysteine Restores Sevoflurane Postconditioning Cardioprotection against Myocardial Ischemia-Reperfusion Injury in Diabetic Rats
por: Lin, Jiefu, et al.
Publicado: (2016)

METTL14 is required for exercise-induced cardiac hypertrophy and protects against myocardial ischemia-reperfusion injury
por: Wang, Lijun, et al.
Publicado: (2022)

Susceptibility to myocardial ischemia reperfusion injury at early stage of type 1 diabetes in rats
por: Li, Haobo, et al.
Publicado: (2013)

Captopril Pretreatment Produces an Additive Cardioprotection to Isoflurane Preconditioning in Attenuating Myocardial Ischemia Reperfusion Injury in Rabbits and in Humans
por: Tian, Yi, et al.
Publicado: (2015)

Effects of Glucose Concentration on Propofol Cardioprotection against Myocardial Ischemia Reperfusion Injury in Isolated Rat Hearts
por: Yao, Xinhua, et al.
Publicado: (2015)

The role of prostaglandin and antioxidant availability in recovery from forearm ischemia–reperfusion injury in humans
por: Carter, Sophie E., et al.
Publicado: (2014)

Knockout of Toll-Like Receptors 2 and 4 Prevents Renal Ischemia-Reperfusion-Induced Cardiac Hypertrophy in Mice
por: Trentin-Sonoda, Mayra, et al.
Publicado: (2015)

Endothelial cell-specific roles for tetrahydrobiopterin in myocardial function, cardiac hypertrophy, and response to myocardial ischemia-reperfusion injury
por: Chuaiphichai, Surawee, et al.
Publicado: (2023)

The Dual Role of Inducible Nitric Oxide Synthase in Myocardial Ischemia/Reperfusion Injury: Friend or Foe?
por: Yu, Xin, et al.
Publicado: (2018)

Prostaglandin E1 Preconditioning Attenuates Liver Ischemia Reperfusion Injury in a Rat Model of Extrahepatic Cholestasis
por: Xu, Feng, et al.
Publicado: (2018)

Ischemic preconditioning vs adenosine vs prostaglandin E1 for protection against liver ischemia/reperfusion injury
por: Radojkovic, M., et al.
Publicado: (2017)

Neuroprotective Effect of Ulinastatin on Spinal Cord Ischemia-Reperfusion Injury in Rabbits
por: Liu, Bingbing, et al.
Publicado: (2015)

Mechanism and Therapies of Oxidative Stress-Mediated Cell Death in Ischemia Reperfusion Injury
por: Li, Haobo, et al.
Publicado: (2018)

Propofol Attenuates Small Intestinal Ischemia Reperfusion Injury through Inhibiting NADPH Oxidase Mediated Mast Cell Activation
por: Gan, Xiaoliang, et al.
Publicado: (2015)

Myocardial ischemia/reperfusion injury: Mechanisms of injury and implications for management (Review)
por: He, Jianfeng, et al.
Publicado: (2022)

Paricalcitol Pretreatment Attenuates Renal Ischemia-Reperfusion Injury via Prostaglandin E(2) Receptor EP4 Pathway
por: Hong, Yu Ah, et al.
Publicado: (2017)

Corrigendum to “Propofol Attenuates Small Intestinal Ischemia Reperfusion Injury through Inhibiting NADPH Oxidase Mediated Mast Cell Activation”
por: Gan, Xiaoliang, et al.
Publicado: (2017)

Role of cardiac renin angiotensin system in ischemia reperfusion injury and preconditioning of heart
por: Agrawal, Vimal, et al.
Publicado: (2016)

Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death
por: Hu, Zhaoyang, et al.
Publicado: (2021)

Teriflunomide treatment exacerbates cardiac ischemia reperfusion injury in isolated rat hearts
por: Alexander, Emily Davis, et al.
Publicado: (2022)

Identification of the Subtypes of Renal Ischemia-Reperfusion Injury Based on Pyroptosis-Related Genes
por: Niu, Xinhao, et al.
Publicado: (2023)

Liver ischemia preconditions the heart against ischemia-reperfusion arrhythmias
por: Noorbakhsh, Mohammad-Foad, et al.
Publicado: (2015)

Protective Effects of N-acetylcysteine and a Prostaglandin E1 Analog, Alprostadil, Against Hepatic Ischemia: Reperfusion Injury in Rats
por: Hsieh, Cheng-Chu, et al.
Publicado: (2014)

Corrigendum to “Paricalcitol Pretreatment Attenuates Renal Ischemia-Reperfusion Injury via Prostaglandin E(2) Receptor EP4 Pathway”
por: Hong, Yu Ah, et al.
Publicado: (2017)

Amelioration of myocardial ischemia/reperfusion injury in diabetes: A narrative review of the mechanisms and clinical applications of dexmedetomidine
por: Sun, Meng, et al.
Publicado: (2022)

Epigenetics in Cardiac Hypertrophy and Heart Failure
por: Liu, Chia-Feng, et al.
Publicado: (2019)

Eprosartan improves cardiac function in swine working heart model of ischemia-reperfusion injury
por: Weymann, Alexander, et al.
Publicado: (2014)

Protective role of fibrates in cardiac ischemia/reperfusion
por: Singh, G., et al.
Publicado: (2012)

Melatonin Attenuates Ischemia/Reperfusion-Induced Oxidative Stress by Activating Mitochondrial Fusion in Cardiomyocytes
por: Ma, Xiaoling, et al.
Publicado: (2022)

Pharmacology of Catechins in Ischemia-Reperfusion Injury of the Heart
por: Ferenczyová, Kristína, et al.
Publicado: (2021)

Downregulation of cardiac PIASy inhibits Cx43 SUMOylation and ameliorates ventricular arrhythmias in a rat model of myocardial ischemia/reperfusion injury
por: Wang, Tingting, et al.
Publicado: (2023)

Single-cell transcriptional profiling of hearts during cardiac hypertrophy reveals the role of MAMs in cardiomyocyte subtype switching
por: Luan, Yi, et al.
Publicado: (2023)

N-Acetylcysteine Attenuates Diabetic Myocardial Ischemia Reperfusion Injury through Inhibiting Excessive Autophagy
por: Wang, Sheng, et al.
Publicado: (2017)

Glucose Metabolism in Cardiac Hypertrophy and Heart Failure
por: Tran, Diem H., et al.
Publicado: (2019)

Noncoding RNAs in Cardiac Hypertrophy and Heart Failure
por: Lu, Peilei, et al.
Publicado: (2022)

Cardiac injury modulates critical components of prostaglandin E(2) signaling during zebrafish heart regeneration
por: FitzSimons, MaryLynn, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dc1vsdudfh7nuaf66333an2h4g